Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Silenor (doxepin) for the Treatment of Insomnia

Drug (Brand / Generic)

Silenor / doxepin

Company / Licensee

Somaxon Pharmaceuticals / Paladin Labs

Therapy Class

Tricyclic antidepressant

Current Indication

Insomnia

Market Sector

CNS

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top